2025-12-25 - Analysis Report
Okay, let's break down the analysis of Procter & Gamble (PG).

**0) Report Structure**

*   **Simple Numbers First:** Presenting the key data points directly from the provided information.
*   **Simple Analysis:**  Offering straightforward interpretations of the data.
*   **Comprehensive Summary:**  Pulling together the key takeaways.

**1) Return Rate Comparison (PG vs. VOO)**

*   **Procter & Gamble Co. (PG) Overview:** Procter & Gamble is a multinational consumer goods corporation that manufactures and markets a wide range of branded products.
*   **PG Cumulative Return:** 26.13%
*   **VOO (S&P 500) Cumulative Return:** 100.88%
*   **Divergence:**
    *   Absolute Divergence: -74.75% (PG significantly underperformed the S&P 500)
    *   Divergence Range: (min: -80.4, max: 24.9)
    *   Relative Divergence: 5.3 (Indicates divergence is near the lowest end of its historical range)

*   **Alpha, Beta, and Performance Analysis**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B)  |
|------------|--------|--------|--------|-------|---------|
| 2015-2017  | 21.0%  | 7.9%   | -8.0%  | 0.0   | 215.1   |
| 2016-2018  | 9.0%   | 67.3%  | -6.0%  | 0.1   | 215.2   |
| 2017-2019  | 24.0%  | 70.4%  | 2.0%   | 0.3   | 292.4   |
| 2018-2020  | 27.0%  | 78.8%  | 4.0%   | 0.4   | 325.7   |
| 2019-2021  | 41.0%  | 78.8%  | -5.0%  | 0.5   | 382.9   |
| 2020-2022  | 13.0%  | 79.4%  | 13.0%  | 0.6   | 354.8   |
| 2021-2023  | 26.0%  | 79.4%  | 24.0%  | 0.4   | 343.1   |
| 2022-2024  | 9.0%   | 79.4%  | -12.0% | 0.4   | 392.5   |
| 2023-2025  | -18.0% | 80.1%  | -83.0% | 0.1   | 338.2   |

*   **Analysis:**

    *   **Underperformance vs. Market:** PG has significantly underperformed the S&P 500 based on cumulative returns.
    *   **Alpha and Beta:** The negative Alpha in several periods, particularly the most recent, suggests PG has underperformed relative to its risk (Beta) and the market. Beta values are generally low, indicating PG is less volatile than the overall market.
    *   **Maximum Drawdown (MDD):** The MDD figures are quite high, indicating significant potential losses during the specified periods. It is also consistently increasing over time
    *   **Capitalization (Cap):** The company's market capitalization has fluctuated, reflecting market sentiment and performance.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 144.46
*   **Last Market Data:** Price 144.49, Previous Close 143.18, Change 0.91
*   **Simple Moving Averages (SMA):**
    *   5-day SMA: 145.626
    *   20-day SMA: 144.9054
    *   60-day SMA: 148.0645

*   **Analysis:** The stock price is slightly below the 5-day and 20-day SMA and significantly below the 60-day SMA. This could indicate a short-term downward trend, but it is also very close to the 20 day SMA. The positive change from the previous close suggests a slight recent rebound.

**3) Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 47.18 (Neutral, neither overbought nor oversold)
*   **PPO:** 0.3263 (Slightly positive, indicating a potential upward trend)
*   **Hybrid Signal:** Buy 100% of cash (7 shares - Very Safe - MRI:0.90). Monthly invest 0.8% of total investment.
*   **Recent Relative Divergence Change:** 1.0 (+): 단기상승 (Short-term rise)
*   **Recent Price Fluctuation:** {'price': 144.49, 'previousClose': 143.18, 'change': 0.91} - Indicates a slight recent rebound.
*   **Expected Return:** -0.5% (Negative, suggesting underperformance relative to S&P 500)

**4) Recent News & Significant Events**

*   **Key Headlines:**
    *   Analyst Upgrades, Tariff Pressures, and a CEO Change (2026)
    *   Analysis of PG Stock's Historical Performance
    *   Opinions on Q1 FY26 Earnings and Price Decline
    *   Stock Hit a 2-Year Low
    *   Institutional Selling (Yousif Capital Management)

*   **Analysis:** The news is mixed. Analyst upgrades are positive, but concerns about tariffs, a CEO change, a recent low, and institutional selling create uncertainty.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.92)
*   **Target Price:** Avg: 168.95, High: 186.00, Low: 148.00
*   **Recent Rating Changes:**  (No specific changes provided)

*   **Analysis:** The analyst consensus is generally positive, with a "Buy" rating and a target price significantly above the current price. This suggests analysts believe the stock is undervalued.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-24 | 2    | 22.39 B$   |
| 2025-04-24 | 1.58 | 19.78 B$   |
| 2025-01-22 | 1.94 | 21.88 B$   |
| 2024-10-18 | 1.65 | 21.74 B$   |
| 2025-10-24 | 1.65 | 21.74 B$   |

*   **Analysis:**

    *   **Revenue Trend:** Revenue has been fluctuating.
    *   **EPS Trend:** EPS has also been fluctuating.  It is important to note that the last two rows of data are duplicated (2025-10-24 and 2024-10-18 have the same values), which is potentially an error.

**6) Financial Information: Revenue, Profitability, and Capital**

Revenue and Profitability:

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $22.39B    | 51.37%        |
| 2025-06-30   | $20.89B    | 49.11%        |
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |

Capital and Profitability:

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-09-30   | $53.27B    | 8.92%  |
| 2025-06-30   | $52.01B    | 6.95%  |
| 2025-03-31   | $52.27B    | 7.21%  |
| 2024-12-31   | $51.17B    | 9.05%  |
| 2024-09-30   | $51.84B    | 7.64%  |

*   **Analysis:**
    *   **Revenue:** Revenue shows some volatility across the quarters.
    *   **Profit Margin:** Profit margins are consistently high, indicating strong profitability.
    *   **Equity:** Equity has been relatively stable.
    *   **ROE:** Return on Equity (ROE) has fluctuated, showing variations in profitability relative to shareholder equity.

**7) Comprehensive Analysis (Summary)**

*   **Underperformance:** PG has significantly underperformed the S&P 500 in cumulative returns. The negative alpha in recent periods confirms underperformance relative to risk.
*   **Mixed Signals:** Technical indicators are giving mixed signals. The MRI suggests a medium investment, but the expected return is negative. The stock price is trading below its 60-day SMA, potentially indicating a short-term downward trend.
*   **Analyst Optimism:** Analyst consensus is positive, with a "Buy" rating and a target price well above the current level.
*   **Financial Health:** Revenue and EPS have fluctuated, but profit margins remain high, suggesting underlying financial strength.
*   **News Uncertainty:** Recent news includes both positive and negative factors, creating uncertainty about the company's short-term prospects.

**Conclusion:**

The analysis paints a somewhat unclear picture.  While analysts are optimistic and the company has strong profitability, PG has underperformed the market, faces some headwinds (tariffs, CEO change), and is showing mixed signals from technical indicators. The potential investor should carefully consider all the factors before making decision.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.